{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:17:02Z","timestamp":1757704622138,"version":"3.32.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.amjms.2024.06.030","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T05:51:39Z","timestamp":1720417899000},"page":"126-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide"],"prefix":"10.1016","volume":"369","author":[{"given":"Kanako","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Jojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Kogai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dai","family":"Tanuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Niitani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshie","family":"Iijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Tomaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Usui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2024.06.030_bib0001","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41588-018-0332-4","article-title":"Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population","volume":"51","author":"Ken","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.amjms.2024.06.030_bib0002","first-page":"507","article-title":"Consensus-based care recommendations for adults with myotonic dystrophy type 1","volume":"8","author":"Tetsuo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.amjms.2024.06.030_bib0003","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/mus.24540","article-title":"Metabolic syndrome in patients with myotonic dystrophy type 1","volume":"52","author":"Vujnic","year":"2015","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.amjms.2024.06.030_bib0004","article-title":"Insulin signaling as a key moderator in myotonic dystrophy type 1","volume":"10","author":"Sylvia","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.amjms.2024.06.030_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1464-5491.2005.01432.x","article-title":"Low-dose metformin improves hyperglicaemia related to myotonic dystrophy","volume":"22","author":"Kouki","year":"2005","journal-title":"Diabetic Med"},{"key":"10.1016\/j.amjms.2024.06.030_bib0006","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.nmd.2011.06.1008","article-title":"Therapeutic effect of metformin against insulin resistance in myotonic dystrophy type 1","volume":"21","author":"Takada","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.amjms.2024.06.030_bib0007","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.0.1460397","article-title":"Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy","volume":"146","author":"Johansson","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.amjms.2024.06.030_bib0008","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.diabres.2003.11.024","article-title":"Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes","volume":"66","author":"Fukushima","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"issue":"9","key":"10.1016\/j.amjms.2024.06.030_bib0009","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/dc10-0200","article-title":"Common genetic variation in GLP1R and insulin secretion in response to exogenous GLP-1 in nondiabetic subjects: a pilot study","volume":"33","author":"Sathananthan","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.amjms.2024.06.030_bib0010","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1089\/dna.2020.5424","article-title":"GLP1R single-nucleotide polymorphisms rs3765467 and rs10305492 affect \u03b2 cell insulin secretory capacity and apoptosis through GLP-1","volume":"39","author":"Li","year":"2020","journal-title":"DNA Cell Biol"},{"issue":"5","key":"10.1016\/j.amjms.2024.06.030_bib0011","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00228-021-03249-z","article-title":"Association between glucagon-like peptide-1 receptor gene polymorphism and treatment response to GLP1R agonists in Chinese patients with type 2 diabetes: a prospective cohort study","volume":"78","author":"Guan","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjms.2024.06.030_bib0012","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neulet.2020.135004","article-title":"Association of GLP-1 receptor gene polymorphisms with sporadic Parkinson's disease in Chinese Han population","volume":"728","author":"Qiu","year":"2020","journal-title":"Neurosci Lett"},{"issue":"2018","key":"10.1016\/j.amjms.2024.06.030_bib0013","article-title":"Polymorphisms in the glucagon-like peptide 1 receptor (GLP-1R) gene are associated with the risk of coronary artery disease in Chinese han patients with type 2 diabetes mellitus: a case-control study","volume":"9","author":"Ma","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.amjms.2024.06.030_bib0014","first-page":"190","article-title":"Mutation search within monogenic diabetes genes in Polish patients with long-term type 1 diabetes and preserved kidney function","volume":"14","author":"Hohendorff","year":"2022","journal-title":"Diabetol Metab Syndrome"},{"issue":"44","key":"10.1016\/j.amjms.2024.06.030_bib0015","doi-asserted-by":"crossref","first-page":"e5155","DOI":"10.1097\/MD.0000000000005155","article-title":"A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes","volume":"95","author":"Han","year":"2016","journal-title":"Medicine"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924013338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924013338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T14:05:13Z","timestamp":1735826713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962924013338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0002962924013338"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.06.030","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.06.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}